Roche Melanoma Pill Can Cause Mild Skin Cancer, Study Reveals

.

Roche Melanoma Pill Roche Melanoma Pill Can Cause Mild Skin Cancer, Study Reveal

A recent research, which was carried out by a team of researchers from the University of California, Roche and Daiichi Sankyo's Plexxikon, has revealed that Roche Holding's pill Zelboraf taken frequently by melanoma patients can result in imparting high risk of developing a rare and less harmful type of skin cancer, dubbed cutaneous squamous cell carcinoma.

It has been revealed that melanoma patients have a mutation known as BRAF, which is curable with the help of vemurafenib. However, most of them further develop a type of skin cancer called cutaneous squamous cell carcinoma. Doctors told that the disease thus developed has to be cured with the aid of surgery.

A research was then conducted by the team of researchers, wherein they enrolled malignant melanoma patients who had got vemurafenib during clinical trials. It was carried out in order to study squamous cell cancer tissue, and to find out the reason of the disease developed after taking the medicine.

The study led them to conclude that in actual, the drugs were not tumour promoters. In fact, more than half of the cases were of RAS mutations, which are probably caused by exposure to the sun. Also, these mutations, when come in contact with the BRAF inhibitors, start growing. In addition, they told that a MEK inhibitor treatment could block this side effect.

Their research has moreover led them to find out that a blend of Zelboraf, which helps in blocking BRAF mutation, and another drug MEK that is for blocking RAS mutation, can help to solve the problem. They analyzed and revealed that the twosome is much more effective than preferring the drugs separately and also has lesser side effects as well.


Latest News

Swiss bank Vontobel Announces 24 Percent Increase in Profit in the First Half of
President Obama Visits Kenya, His Father’s Birth Place
National Highway Traffic Safety Administration Slaps $105M Fine on Fiat Chrysler
Wealthy, Well Educated People in Early 60’s More at Risk of Harmful Drinking
Amazon’s Strong Second Quarter Results Boost the Company’s Share
Weak PMI in China Raises Concern and Asian Shares Drop on Friday
Even with Lower Sales, Coca-Cola’s Profit Increases
Qualcomm Plans to Cut Jobs and May go in for a Spin Off
Bruce Thompson to Step Down as the Chief Financial Officer of Bank of America th
Data Reveals Rise in U.S Stock Pile: Prices Fall this Week
Weak Quarterly Reports Lower Stocks on Dow and Standard & Poor’s 500 Index
Reports say Arrests Related to Stocks and Bitcoin Fraud Connected to Last Year’s